Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Basal Insulin During Ramadan Fasting in Type 2 Diabetic Patients
NCT06826547Phase 1Active, not recruiting
- Sponsor
- University of Tunis El Manar
- Start
- Feb 2025
- Primary completion
- Dec 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Tunis El Manar. Primary endpoints: Fructosamine levels at 6 weeks, Interleukin-6 levels at 6 weeks and 4 more. Started Feb 2025; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06826547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06826547.